Copyright 2004 American Medical Association. All Rights Reserved.Applicable FARS/DFARS Restrictions Apply to Government Use.2004
Errors in Text, Figures, and Table. In thearticle titled "A Placebo-Controlled 18-Month Trial of Lamotrigine and LithiumMaintenance Treatment in Recently Manic or Hypomanic Patients With BipolarI Disorder," published in the April 2003 issue of the ARCHIVES (2003;60:392-400),the last line of the first paragraph on page 393 should have read "In a secondstudy with parallel-group and crossover components, lamotrigine monotherapywas more effective than placebo or gabapentin in the treatment of patientswith bipolar and unipolar mood disorders who were refractory to or intolerantof lithium, valproic acid, or carbamazepine.24"; the P value in Figure 1 B for Lithium vs Placebo on page 396 should haveread P = .07; the P valuein Figure 2 A for Lamotrigine vs Placebo on page 397 should have read P = .02; and the table heading in Table 5 on page 397 shouldhave read Lamotrigine (n = 58). The ARCHIVES regrets the errors.
A Placebo-Controlled 18-Month Trial of Lamotrigine and Lithium MaintenanceTreatment in Recently Manic or Hypomanic Patients With Bipolar I Disorder—Correction. Arch Gen Psychiatry. 2004;61(7):680. doi:10.1001/archpsyc.61.7.680